Target Name: USP17L27
NCBI ID: G728393
Review Report on USP17L27 Target / Biomarker Content of Review Report on USP17L27 Target / Biomarker
USP17L27
Other Name(s): Ubiquitin specific peptidase 17 like family member 27 | LOC728373 | LOC728400 | LOC728379 | LOC728419 | similar to deubiquitinating enzyme 3 | Deubiquitinating enzyme 17 | LOC728393 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 | ubiquitin specific peptidase 17 like family member 27 | Ubiquitin-specific-processing protease 17 | LOC728369 | Ubiquitin thioesterase 17 | LOC728405 | U17LO_HUMAN

USP17L27: A Potential Drug Target and Biomarker for Ubiquitin Specific Peptidase 17-Like Family Member 27

Ubiquitin specific peptidase 17-like family member 27 (USP17L27) is a protein that plays a crucial role in the regulation of protein stability and degradation in various cellular processes.USP17L27 is a member of the ubiquitin specific peptidase family 17, which are involved in the degradation of Ubiquitin, a protein that plays a central role in the regulation of cellular processes such as cell division, apoptosis, and signaling pathways.USP17L27 is expressed in various tissues and cells and has been implicated in the development and progression of various diseases, including cancer.

Drug Target Potential

The potential drug targets for USP17L27 are numerous and varied.One of the main targets of USP17L27 is its role in the regulation of protein stability and degradation.USP17L27 has been shown to play a role in the degradation of various proteins, including histone H3, which is involved in the regulation of gene expression and DNA replication.USP17L27 has also been shown to interact with and regulate the activity of other proteins, including the develin protein (DEPV), a protein that is involved in the regulation of cell adhesion and migration.

Another potential drug target for USP17L27 is its role in the regulation of cellular signaling pathways.USP17L27 has been shown to play a role in the regulation of various signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth and differentiation.USP17L27 has also been shown to interact with and regulate the activity of other proteins, including the transcription factor, nuclear factor of activated T cells (NFAT), which is involved in the regulation of gene expression.

Biomarker Potential

USP17L27 may also be a useful biomarker for the diagnosis and prognosis of various diseases.The degradation of Ubiquitin by USP17L27 has been shown to be altered in various diseases, including cancer.USP17L27 has also been shown to be involved in the regulation of cellular processes that are altered in various diseases, including inflammation and neurodegeneration.

Conclusion

In conclusion, USP17L27 is a protein that plays a crucial role in the regulation of protein stability and degradation and has been implicated in the development and progression of various diseases.The potential drug targets for USP17L27 are numerous and varied, including its role in the regulation of cellular signaling pathways and its role in the regulation of protein stability and degradation.USP17L27 may also be a useful biomarker for the diagnosis and prognosis of various diseases.Future research is needed to fully understand the role of USP17L27 in the regulation of cellular processes and its potential as a drug target.

Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 27

Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection

The "USP17L27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1